Page 2158 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 127 Regulatory Mechanisms in Hemostasis 1911

REFERENCES 21. Crawley JT, de Groot R, Xiang Y, et al: Unraveling the scissile bond:
how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood
1. Macfarlane RG: An Enzyme Cascade in the Blood Clotting Mechanism, 118(12):3212–3221, 2011.
and Its Function as a Biochemical Amplifier. Nature 202:498–499, 1964. 22. Sadler JE: Von Willebrand factor, ADAMTS13, and thrombotic throm-
2. Davie EW, Ratnoff OD: Waterfall Sequence for Intrinsic Blood Clotting. bocytopenic purpura. Blood 112(1):11–18, 2008.
Science 145:1310–1312, 1964. 23. Wood JP, Ellery PE, Maroney SA, et al: Biology of tissue factor pathway
3. Hoffman M, Monroe DM, Roberts HR: Cellular interactions in hemo- inhibitor. Blood 123(19):2934–2943, 2014.
stasis. Haemostasis 26(Suppl 1):12–16, 1996. 24. Wood JP, Bunce MW, Maroney SA, et al: Tissue factor pathway
4. Huntington J: Structural Insights into the Life History of Thrombin. In inhibitor-alpha inhibits prothrombinase during the initiation of blood
Tanaka K, Davie E, Ikeda Y, et al, editors: Recent Advances in Thrombosis coagulation. Proc Natl Acad Sci USA 110(44):17838–17843, 2013.
and Hemostasis 2008, Japan, 2008, Springer, pp 80–106. 25. Wood JP, Ellery PE, Maroney SA, et al: Protein S is a cofactor for platelet
5. Mann KG, Brummel K, Butenas S: What is all that thrombin for? J and endothelial tissue factor pathway inhibitor-alpha but not for cell
Thromb Haemost 1(7):1504–1514, 2003. surface-associated tissue factor pathway inhibitor. Arterioscler Thromb
6. Buller HR, Gailani D, Weitz JI: Factor XI antisense oligonucleotide for Vasc Biol 34(1):169–176, 2014.
venous thrombosis. N Engl J Med 372(17):1672, 2015. 26. Huntington JA, Read RJ, Carrell RW: Structure of a serpin-protease
7. Kenne E, Renne T: Factor XII: a drug target for safe interference with complex shows inhibition by deformation. Nature 407(6806):923–926,
thrombosis and inflammation. Drug Discov Today 19(9):1459–1464, 2000.
2014. 27. Bray B, Lane DA, Freyssinet JM, et al: Anti-thrombin activities of
8. Fehlhammer H, Bode W, Huber R: Crystal structure of bovine tryp- heparin. Effect of saccharide chain length on thrombin inhibition by
sinogen at 1-8 A resolution. II. Crystallographic refinement, refined heparin cofactor II and by antithrombin. Biochem J 262(1):225–232,
crystal structure and comparison with bovine trypsin. J Mol Biol 1989.
111(4):415–438, 1977. 28. Rezaie AR, Olson ST: Calcium enhances heparin catalysis of the
9. Huntington JA: Slow thrombin is zymogen-like. J Thromb Haemost antithrombin-factor Xa reaction by promoting the assembly of an
7(Suppl 1):159–164, 2009. intermediate heparin-antithrombin-factor Xa bridging complex. Dem-
10. Eigenbrot C, Kirchhofer D: New insight into how tissue factor allosteri- onstration by rapid kinetics studies. Biochemistry 39(39):12083–12090,
cally regulates factor VIIa. Trends Cardiovasc Med 12(1):19–26, 2002. 2000.
11. Bjork I, Olson ST: Antithrombin. A bloody important serpin. Adv Exp 29. Rau JC, Beaulieu LM, Huntington JA, et al: Serpins in thrombosis,
Med Biol 425:17–33, 1997. hemostasis and fibrinolysis. J Thromb Haemost 5(Suppl 1):102–115,
12. Verhamme P, Hoylaerts MF: The pivotal role of the endothelium in 2007.
haemostasis and thrombosis. Acta Clin Belg 61(5):213–219, 2006. 30. Esmon CT, Owen WG: Identification of an endothelial cell cofactor
13. Butenas S: Tissue factor structure and function. Scientifica. 2012:964862, for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA
2012. 78(4):2249–2252, 1981.
14. Gardiner EE, Andrews RK: Structure and function of platelet receptors 31. Mohan Rao LV, Esmon CT, Pendurthi UR: Endothelial cell protein
initiating blood clotting. Adv Exp Med Biol 844:263–275, 2014. C receptor: a multiliganded and multifunctional receptor. Blood
15. Nuyttens BP, Thijs T, Deckmyn H, et al: Platelet adhesion to collagen. 124(10):1553–1562, 2014.
Thromb Res 127(Suppl 2):S26–S29, 2011. 32. Esmon CT: The protein C pathway. Chest 124(3 Suppl):26S–32S,
16. De Candia E: Mechanisms of platelet activation by thrombin: a short 2003.
history. Thromb Res 129(3):250–256, 2012. 33. Reitsma PH: Protein C deficiency: from gene defects to disease. Thromb
17. Kane WH, Davie EW: Blood coagulation factors V and VIII: structural Haemost 78(1):344–350, 1997.
and functional similarities and their relationship to hemorrhagic and 34. Griffin JH, Heeb MJ, Kojima Y, et al: Activated protein C resistance:
thrombotic disorders. Blood 71(3):539–555, 1988. molecular mechanisms. Thromb Haemost 74(1):444–448, 1995.
18. Lechtenberg BC, Murray-Rust TA, Johnson DJ, et al: Crystal structure 35. Langdown J, Luddington RJ, Huntington JA, et al: A hereditary bleed-
of the prothrombinase complex from the venom of Pseudonaja textilis. ing disorder resulting from a premature stop codon in thrombomodulin
Blood 122(16):2777–2783, 2013. (p.Cys537Stop). Blood 124(12):1951–1956, 2014.
19. Pomowski A, Ustok FI, Huntington JA: Homology model of human 36. Chapin JC, Hajjar KA: Fibrinolysis and the control of blood coagulation.
prothrombinase based on the crystal structure of Pseutarin C. Biol Chem Blood Rev 29(1):17–24, 2015.
395(10):1233–1241, 2014.
20. Lenting PJ, Casari C, Christophe OD, et al: von Willebrand factor: the
old, the new and the unknown. J Thromb Haemost 10(12):2428–2437,
2012.